Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation

Abstract

Olanzapine exposure in individual patients was predicted using PBPK M&S. Repurposing of available PBPK M&S platforms is an option for model-informed precision dosing and requires further study to examine clinical potential.